TNF-α antagonists not only inhibit CAC induction in mice by limiting TNF-induced infiltration of neutrophils and macrophages (12) but also reduce the risk of both dysplasia and CAC when combined with other anti-inflammatory medications in the clinic (15). The gene discussed is TNF; the disease is dysplasia.